Shandong Jincheng Pharmaceutical Group (300233.SZ) announced that its wholly-owned subsidiary Beijing Jincheng Tail Pharmaceutical Co., Ltd. (hereinafter referred to as "Jincheng Tail") has received the "Drug GMP Compliance Inspection Notification" (No.: Jingyaoyan Drug GMP[2024]020072) issued by the Beijing Municipal Drug Administration.
Inspection scope and related production workshops, production lines: Lornoxicam (Registration number: Y20220000707) (Hebei Cangzhou City Lingang Economic and Technological Development Zone West Area Beijing Pharmaceutical Industry Park east of Jingwu Road north of Weier Road, workshop: Lornoxicam production line).
Lornoxicam is a non-steroidal anti-inflammatory drug used for antipyresis and analgesia. It is the chloride of tenoxicam. Its effects are similar to tenoxicam, providing analgesic, anti-inflammatory, and antipyretic properties.
